Search

Search Results

• Infliximab treatment in a case of rheumatoid scleromalacia perforans

  R. Herrera-Esparza, E. Avalos-Diaz

  212-215

  Published:

  1139

  PDF: 930
• 

  Urticarial vasculitis as an initial manifestation of colonic carcinoma: a case report and review of the literature

  A.A. Younis

  259-263

  20-12-2018

  Published: 20 December 2018

  1339

  PDF: 1005

• Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?

  F. Atzeni, P. Sarzi-Puttini

  1-3

  Published:

  1459

  PDF: 682

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  Published:

  818

  PDF: 1953
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  Published: 19 November 2020

  1400

  PDF: 949

• Wegener’s granulomatosis: an analysis of 50 patients

  G. Di Comite, G. Bonavida, E. Bozzolo, S. Bozzolo, S. Bianchi, G. Ciboddo, M. Tresoldi, L. Praderio, M.G. Sabbadini

  187-192

  11-04-2005

  Published: 11 April 2005

  786

  PDF: 1497

• The hand: a window to arthritis

  G. Filippou, B. Frediani, A. Gallo, L. Menza, P. Falsetti, F. Baldi, M. Galeazzi, R. Marcolongo

  71-74

  Published:

  1236

  PDF: 982
• 

  Ultrasound imaging in crystal arthropathies: a pictorial review

  G. Tamborrini, T. Hügle, V. Ricci, G. Filippou

  19-12-2023

  Published: 19 December 2023

  1665

  PDF: 784

  SUPPLEMENTARY MATERIAL: 204

• Milwaukee shoulder syndrome (apatite associated destructive arthritis): therapeutic aspects

  O. Epis, E. Viola, E. Bruschi, F. Benazzo, C. Montecucco

  69-77

  Published:

  1918

  PDF: 4294
• 

  Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease

  D. Rincón-Riaño, D.G. Fernández-Ávila, D. Acero-Molina, J.M. Bello Gualtero , C. Romero-Sánchez

  13-09-2022

  Published: 13 September 2022

  1268

  PDF: 699

• Wars in the history of rheumatology

  G. Pasero, P. Marson

  332-337

  Published:

  1330

  PDF: 899

• Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

  Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

  31-38

  Published:

  1744

  PDF: 2483
• 

  Psoriatic spondyloarthritis and Sjögren syndrome: a casual association?

  V. Bruzzese, C. Marrese, P. Scolieri, J. Pepe

  170-172

  19-11-2020

  Published: 19 November 2020

  915

  PDF: 584
• 

  Poncet’s disease diagnostic criteria decodes conundrum: Poncet’s vs pseudo Poncet’s

  V. Shobha, A.M. Desai

  46-50

  01-04-2019

  Published: 1 April 2019

  1332

  PDF: 1000
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  185-194

  09-11-2011

  Published: 9 November 2011

  1286

  PDF: 1190

• Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

  A. Spadaro, V. Riccieri, C. Alessandri, R. Scrivo, G. Valesini

  116-120

  Published:

  1163

  PDF: 1120
• 

  Sjögren’s syndrome and mean platelet volume

  M. E. Tezcan, Ş. Demir, M. Sargın, M. Aliustaoğlu, B. Göker

  33-34

  30-06-2015

  Published: 30 June 2015

  1265

  PDF: 1047
• 

  Pediatric fibromyalgia

  D. Buskila, J. Ablin

  230-237

  28-09-2012

  Published: 28 September 2012

  3548

  PDF: 2627

• Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis

  C. Salvarani, I. Olivieri, F. Cantini, A. Marchesoni, L. Punzi, R. Scarpa, M. Matucci Cerinic

  133-138

  Published:

  1336

  PDF: 862

• Role of chemokines in the pathogenesis of rheumatoid synovitis

  F. Ingegnoli, A. Manzo, F. Fantini, R. Caporali, C. Montecucco, N. Pipitone, C. Pitzalis

  12-18

  Published:

  706

  PDF: 777

• Frequency of pathology in a large natural sample from Natural Trap Cave with special remarks on erosive disease in the Pleistocene

  B.M. Rothschild, L.D. Martin

  58-65

  Published:

  1139

  PDF: 1003

• On the main stages of the history of intra-articular therapy

  P. Marson, G. Pasero, L. Punzi, G. Zanchin

  262-268

  Published:

  1287

  PDF: 1087

• A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens

  Giovanna Cuomo, Gabriella Molinaro, Giovanni La Montagna, Sergio Migliaresi, Gabriele Valentini

  22-25

  Published:

  1455

  PDF: 1939

• Leptin: regulatory role in bone metabolism and in flogosis

  G. De Marchi, G.D. Ferraccioli

  217-225

  Published:

  1163

  PDF: 3572

• Rheumatic diseases in the Corpus Hippocraticum

  G. Squillace

  1-5

  Published:

  735

  PDF: 753

• THE HISTOPATHOLOGY OF PSORIASIS

  G. De Rosa, C. Mignogna

  46-48

  Published:

  3963

  PDF: 5801

• HAQ-DI Italian version in systemic sclerosis

  G. La Montagna, G. Cuomo, I. Chiarolanza, L. Ruocco, G. Valentini

  112-115

  Published:

  1458

  PDF: 1869

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  Published:

  815

  PDF: 2645

• Inflammatory bowel diseases and spondyloarthritis: a focus on female patients

  C. Caranfil, G. Lorenzon, B. Barberio, R. Ramonda, E.V. Savarino, F. Zingone

  11-09-2024

  Published: 11 September 2024

  745

  PDF: 263

• Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the “3E initiative”

  F. De Leonardis, S. Aliverini, E. Bonacci, A.M. Buono, S. Bombardieri, G.F. Ferraccioli, C. Montecucco, L. Sinigaglia, F. Trotta, G. Valentini

  34-45

  Published:

  1946

  PDF: 2202
• 

  Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?

  K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid

  203-208

  28-01-2020

  Published: 28 January 2020

  1632

  PDF: 776

• Are there any positive effects of TNF-alpha blockers on bone metabolism?

  B. Seriolo, S. Paolino, A. Sulli, M. Cutolo

  199-205

  Published:

  1148

  PDF: 1075

• Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report

  V.F. Azevedo, C.F. Pietrovski, M. de Almeida Santos Jr

  283-285

  Published:

  1202

  PDF: 1210

• Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

  G. Lapadula

  22-29

  Published:

  722

  PDF: 1040

• Some historical considerations on the inflammatory theory of atherosclerosis

  P. Marson, G. Zanchin, C. Stefanutti

  215-219

  Published:

  992

  PDF: 867

• Chronic polyarthritis in a patient affected by sarcoidosis and chronic HCV infection. Case report and review of the literature

  A. Cossu, P.A. Cossu, A. Carcassi

  144-149

  Published:

  776

  PDF: 2080

• Rheumatic diseases at the court of the Medici of Florence: the so-called “gout” of the Medici

  G. Fornaciari, V. Giuffra

  229-237

  Published:

  1008

  PDF: 767

• Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis

  M. Vadacca, R. Bruni, F. Caccipaglia, F. Serino, L. Arcarese, F. Buzzulini, G. Coppolino, A. Rigon, N. Terminio, A. Afeltra

  50-56

  Published:

  1828

  PDF: 1038

• Relapsing polycondritis associated with microscopic polyangiitis: description of a clinical case

  L. Breviglieri, F. Zizzi, P. Rocchi, G. Frascà, G. D’Arcangelo, C. Rimondi, L. Frizziero

  151-155

  Published:

  886

  PDF: 941